Vivo Ventures Closes $375 Million US-China Life Science Fund
1/3/2012 2:08:16 PM
January 3, 2012 -- Vivo Ventures, a California healthcare investment firm that invests in both US and China life science companies, closed its seventh fund, Vivo Ventures VII, at $375 million. In the US, the fund will target US companies in the later stage of development. Its China investments will seek enterprises that are producing revenues. More details....
comments powered by